Investor Presentaiton
Innovent Academy and Key Drug Discovery Strategies
Innovent Academy
Monoclonal
antibodies
Objective: To develop and launch First-in-Class product
globally as Innovent's powerful discovery engine
Key Therapeutic Focus: Oncology, metabolic diseases,
immunology, and ophthalmology
Position: Global leading drug discovery platform for
both scientific research and technology application
Structure: Immunology, Protein Antibody Engineering,
Pharmacology, Translational Medicine and Cell Therapy
US Lab (Maryland)
Position: R&D center in the US;
Important component of Innovent
global R&D infrastructure
Focus: Disease mechanism study and
technology platform development
Goal: Connect frontline global
innovation and clinical practices;
accelerate translation of scientific
discovery into medicines
Biology-driven, Technology-enabling
(50+ drug discovery projects ongoing in Innovent Academy)
Oncology: Immunotherapy and Targeted therapy
Multi-specific
antibodies
ADC
Cell Therapy
Non-Oncology: Autoimmunity, Metabolic diseases,
Autoimmunity
Ophthalmology
Metabolic diseases
Ophthalmology
Innovent
Confidential
Copyright©2021 Innovent Biologics
Ope
A
FATTY LIVER
Clary mude
mea
Opc re
39View entire presentation